Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Breast Cancer Risk Investigation in Grown-up Hodgkin Lymphoma Patients Treated With MBVD.

NCT07120217 is registered in ClinicalTrials.gov with Federico II University as lead sponsor.

NCT NCT07120217
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07120217 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Breast Cancer Risk Investigation in Grown-up Hodgkin Lymphoma Patients Treated With MBVD.
Lead sponsor
Federico II University
Phase
Observational
Overall status
Completed
Start date
January 1, 2008
Completion date
August 1, 2025
Enrollment
200 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, hodgkin disease, liposomal doxorubicin